Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 69
Filtrar
1.
Rev. méd. Urug ; 39(4)dic. 2023.
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-1530274

RESUMO

En el mundo un paciente diabético gasta entre dos y tres veces más que el no diabético. El pie diabético disminuye la calidad de vida, aumenta la morbimortalidad y la carga económica del sistema de salud. Objetivo: comunicar la investigación realizada sobre costos directos en el tratamiento de la úlcera del pie diabético. Material y método: estudio observacional, descriptivo, retrospectivo de pacientes asistidos en la Unidad de Pie del Hospital de Clínicas, Universidad de la República, entre octubre de 2014 y septiembre de 2016. Se estimaron gastos directos del tratamiento ambulatorio e internación a través de información de la historia clínica. El horizonte de tratamiento fue de tres meses. Se calcularon los gastos en unidades reajustables (UR), pesos y dólares. Los gastos se actualizaron a octubre del 2022 utilizando el índice de precios al consumo (IPC), ajustado a la tasa de inflación acumulada. Resultados: incluimos 49 pacientes, 11 mujeres y 38 hombres, edad promedio 61,5 años. El gasto general fue mayor a 400.000 dólares, con el mayor costo en gastos de internación. El gasto total promedio por paciente fue de 8.799 dólares. El tratamiento convencional fue 3.707,93 dólares, la amputación mayor 32.003,61 dólares y amputación menor 12.385,34 dólares. El gasto en internación fue muy superior al del paciente ambulatorio. En emergencia, 28 pacientes gastaron 4.396 dólares. El incremento de costos al año 2022 fue de 37,45%, suponiendo un gasto general de 16.682.993,4 pesos o 410.830,2 dólares. Conclusión: primera evaluación en nuestro país de estimación de gastos en pie diabético. El costo de la úlcera genera una carga económica notoria y en aumento. La gravedad inicial de la úlcera determina ingresos con elevados costes. Los gastos de internación y amputaciones representan la mayor erogación económica.


On a global scale, a diabetic patient incurs healthcare expenses that are 2 to 3 times higher than those of a non-diabetic individual. Diabetic foot syndrome reduces the quality of life, increases morbidity and mortality, and places an economic burden on the healthcare system. Objective: Communicating the research conducted on direct costs in the treatment of diabetic foot ulcers. Method: Observational, descriptive, retrospective study of patients treated at the Foot Unit of the Hospital de Clínicas (UDELAR) between October 2014 and September 2016. Direct treatment costs for outpatient care and hospitalization were estimated using information from the medical records. The treatment horizon extended over a period of 3 months. Expenses were calculated in readjustable units, Uruguayan pesos (UYU), and United States dollars (USD). Expenses were updated to October 2022 using the Consumer Price Index (IPC) adjusted for the cumulative inflation rate. Results: 49 patients were included in the study: 11 women and 38 men, average age was 61.5 years old. The overall expenditure exceeded 400,000 USD, with the highest cost attributed to hospitalization expenses. The average total expenditure per patient amounted to 8,799 USD. The cost of conventional treatment was 3,707.93 USD, major amputation represented USD 32,003.61, and minor amputation USD 12,385.34. Hospitalization expenses significantly exceeded those of outpatient care. In the emergency department, 28 patients spent USD 4,396. The increase in costs by the year 2022 amounted to 37.45%, resulting in a total expenditure of UYU 16,682,993.4 (Uruguayan pesos) or USD 410,830.2. Conclusions: It was the first assessment in our country to estimate diabetic foot costs. The cost of ulcer management imposes a significant and increasing economic burden. The initial severity of the ulcer results in hospitalization which implies high associated costs. Hospitalization and amputation costs constitute the most substantial economic expenditure.


Em todo o mundo, um paciente diabético gasta entre 2 e 3 vezes mais do que um paciente não diabético. O pé diabético reduz a qualidade de vida, aumenta a morbimortalidade e a carga económica no sistema de saúde. Objetivos: Comunicar os resultados da pesquisa realizada sobre os custos diretos no tratamento das úlceras do pé diabético. Materiais e métodos: Estudo observacional, descritivo e retrospectivo de pacientes atendidos na Unidade de Pie do Hospital de Clínicas (UDELAR), entre outubro de 2014 e setembro de 2016. Foram estimados gastos diretos com tratamento ambulatorial e internação, por meio de informações do prontuário do paciente. O período de tratamento estudado foi de 3 meses. As despesas foram calculadas em Unidades Ajustáveis, em pesos uruguaios (UYU) e em dólares norte-americanos (USD). As despesas foram atualizadas para outubro de 2022 pelo Índice de Preços ao Consumidor (IPC) ajustado à inflação acumulada. Resultados: Foram incluídos 49 pacientes: 11 mulheres e 38 homens com idade média de 61,5 anos. A despesa global foi superior a US$ 400.000, com o maior custo em despesas de hospitalização. A despesa total média por paciente foi de US$ 8.799. Os custos por tratamento foram: Tratamento convencional US$ 3.707,93 USD, amputação maior US$ 32.003,61 e amputação menor US$ 12.385,34. O gasto com internação foi muito superior ao do ambulatório. No atendimento de emergência 28 pacientes gastaram US$ 4.396. O aumento dos custos até 2022 foi de 37,45%, assumindo uma despesa geral de UY$ 16.682.993,4 ou US$ 410.830,2 USD. Conclusão: Esta é a primeira avaliação de estimativa de gastos com pé diabético realizada no Uruguai. O custo das úlceras gera uma carga económica notável e crescente. A gravidade inicial da úlcera determina internações com custos elevados. As despesas com hospitalização e amputação representam o maior gasto financeiro.

2.
Environ Health ; 22(1): 31, 2023 03 30.
Artigo em Inglês | MEDLINE | ID: mdl-36991377

RESUMO

BACKGROUND: The adverse effects of air pollution on human health include many diseases and health conditions associated with mortality, morbidity and disability. One example of these outcomes that can be translated into economic costs is the number of days of restricted activity. The aim of this study was to assess the effect of outdoor exposure to particulate matter with an aerodynamic diameter less than or equal to 10 and 2.5 µm (PM10, PM2.5), nitrogen dioxide (NO2), and ozone (O3), on restricted activity days. METHODS: Observational epidemiological studies with different study designs were included, and pooled relative risks (RR) with 95% confidence intervals (95%CI) were calculated for an increase of 10 µg/m3 of the pollutant of interest. Random-effects models were chosen because of the environmental differences between the studies. Heterogeneity was estimated using prediction intervals (PI) and I-Squared (I2) values, while risk of bias was assessed using a tool developed by the World Health Organization specifically designed for air pollution studies, and based on different domains. Subgroup and sensitivity analyses were performed where possible. The protocol for this review was registered with PROSPERO (CRD42022339607). RESULTS: We included 18 articles in the quantitative analysis. Associations between pollutants and restricted activity days in time-series studies of short-term exposures, measured as work-loss days, school-loss days, or both were significant for PM10 (RR: 1.0191; 95%CI: 1.0058-1.0326; 80%PI: 0.9979-1.0408; I2: 71%) and PM2.5 (RR: 1.0166; 95%CI: 1.0050-1.0283; 80%PI: 0.9944-1.0397; I2: 99%), but not for NO2 or O3. Some degree of heterogeneity between studies was observed, but sensitivity analysis showed no differences in the direction of the pooled relative risks when studies with a high risk of bias were excluded. Cross-sectional studies also showed significant associations for PM2.5 and restricted activity days. We could not perform the analysis for long-term exposures because only two studies analysed this type of association. CONCLUSION: Restricted activity days and related outcomes were associated with some of the pollutants under evaluation, as shown in studies with different designs. In some cases, we were able to calculate pooled relative risks that can be used for quantitative modelling.


Assuntos
Poluentes Atmosféricos , Poluição do Ar , Poluentes Ambientais , Ozônio , Humanos , Poluentes Atmosféricos/efeitos adversos , Poluentes Atmosféricos/análise , Dióxido de Nitrogênio/efeitos adversos , Dióxido de Nitrogênio/análise , Estudos Transversais , Poluição do Ar/efeitos adversos , Poluição do Ar/análise , Material Particulado/efeitos adversos , Material Particulado/análise , Ozônio/efeitos adversos , Ozônio/análise , Exposição Ambiental/efeitos adversos , Exposição Ambiental/análise , Estudos Observacionais como Assunto
3.
Rev. med. Urug ; 39(1): e701, 2023.
Artigo em Espanhol | LILACS, BNUY | ID: biblio-1431904

RESUMO

La encefalitis límbica (EL) autoinmune es una afección neurológica infrecuente de curso subagudo con manifestaciones neuropsicológicas. Actualmente el tratamiento inmunoterápico agudo o de mantenimiento es dirigido según el anticuerpo neural acompañante y la presencia o ausencia de cáncer. Presentamos el caso de una mujer de 52 años con hipotiroidismo autoinmune, síndrome de secreción inadecuada de hormona antidiurética (SIADH) e hiponatremia (hipoNa) persistente, con evolución progresiva de perdida de la memoria y crisis distónicas faciobraquiales (DFBC) a quien se le realiza un diagnóstico oportuno de encefalitis límbica. Recibió tratamiento intravenoso combinado en base a corticoides e inmunoglobulina con buena respuesta y morbilidad mínima neuropsicológica. El reconocimiento de esta patología permite un diagnóstico y tratamiento temprano, imprescindible para mejorar el pronóstico de estos pacientes.


Autoimmune limbic encephalitis is a rather unusual neurological condition with subacute progression and neuropsychological symptoms. Currently, acute or maintenance treatment with immunotherapy is targeted depending on the accompanying neural specific antibody and the presence or absence of cancer. The study presents the case of a 52-year-old woman suffering from autoimmune hypothyroidism, syndrome of inappropriate secretion of anti-diuretic hormone (SIADH) and persistent hyponatremia, with progressive evolution which involved memory loss and faciobrachial dystonic seizures (FBDS). She was timely diagnosed with limbic encephalitis and was treated with intravenous combined corticosteroids and immunoglobulin therapy. Response was good, with minimum neuropsychological. Recognizing this condition allows for early diagnosis and treatment, what is key to improve the prognosis of these patients.


A encefalite límbica (LE) autoimune é uma condição neurológica rara de curso subagudo com manifestações neuropsiquiátrica. Atualmente, o tratamento com imunoterapia aguda ou de manutenção é orientado de acordo com o anticorpo neural e a presença ou ausência de câncer. Apresentamos o caso de uma mulher de 52 anos com hipotireoidismo autoimune, síndrome de secreção inapropriada de hormônio antidiurético e hiponatremia persistente, com evolução progressiva da perda de memória e crises distônicas faciobraquiais que foi diagnosticada oportunamente como encefalite límbica. Recebeu tratamento endovenoso combinado à base de corticoide e imunoglobulina com boa resposta e morbidade neuropsiquiátrica mínima. O reconhecimento desta patologia permite um diagnóstico e tratamento precoces, essenciais para melhorar o prognóstico desses pacientes.


Assuntos
Encefalite Límbica/terapia , Hiponatremia , Síndrome de Secreção Inadequada de HAD
4.
Rev. méd. Urug ; 38(1): e38110, 2022.
Artigo em Espanhol | LILACS, UY-BNMED, BNUY | ID: biblio-1389667

RESUMO

Resumen: La complicación más frecuente de la úlcera del pie diabético (UPD) es la infección, siendo el desencadenante principal de amputaciones menores y mayores. La osteomielitis (OM) está presente hasta en el 60% de los casos y su tratamiento es un desafío, generando controversias según las formas clínicas de presentación. La resección del hueso infectado ha sido el tratamiento estándar, pudiendo generar secuelas funcionales y úlceras recurrentes. En las últimas dos décadas se propuso el tratamiento antimicrobiano con cirugía conservadora o sin cirugía en las lesiones del antepie, con resultados satisfactorios. Objetivo: presentar los resultados del tratamiento médico de la osteomielitis del pie en pacientes diabéticos, priorizando resecciones mínimas que eviten amputaciones desestabilizantes de su biomecánica. Se evaluaron seis pacientes con diabetes mellitus (DM) tratados en la Unidad de Pie, con osteomielitis de falanges, metatarsianos y calcáneo, tratados con antibióticos durante 7±2 semanas y con resecciones limitadas al antepié, con buena evolución. Durante un año de seguimiento hubo ausencia de cualquier signo de infección en el sitio inicial o contiguo de la lesión, preservando el apoyo. Conclusión: la cirugía con resección mínima sin amputación local o de alto nivel tiene éxito en casos seleccionados de osteomielitis del pie diabético. Deben realizarse ensayos prospectivos para determinar sus beneficios frente a otros enfoques.


Abstract: Infection is the most frequent complication in diabetic foot ulcers, and it is the main cause of minor and major lower extremities amputations. Osteomyelitis accounts for 60% of cases and it constitutes a challenge when it comes to treatment, since controversies arise depending on its clinical presentation. Resection of the infected bone has been the golden standard, despite it may cause functional sequelae and recurring ulcers. In the last two decades antibiotic therapy has emerged, combined with a conservative surgical approach or no surgery in forefoot lesions, the results being satisfactory. Objective: to present the results of medical treatment of foot osteomyelitis in diabetic patients, prioritizing minimal resections that avoid amputations which alter the biomechanics of the foot. The study evaluated 6 diabetic patients assisted at the Diabetic Foot Unit, with phalanx, metatarsal and calcaneal osteomyelitis. They received antibiotic therapy for 7 ± 2 weeks and resections were limited to the forefoot, showing good evolution. During a one-year follow-up, there were no signs of infection in the initial site or adjacent to the lesion, support of the foot being preserved. Conclusion: minimum resection surgery with no local or major amputation is a successful therapy in selected cases of diabetic foot osteomyelitis. Prospective trials are necessary to determine benefits of this management when compared to other approaches.


Resumo: A complicação mais frequente da úlcera do pé diabético (UFD) é a infecção, sendo o principal desencadeador de amputações menores e maiores. A osteomielite (OM) está presente em até 60% dos casos e seu tratamento é um desafio, gerando controvérsias dependendo de suas formas clínicas de apresentação. A ressecção do osso infectado tem sido o tratamento padrão, podendo gerar sequelas funcionais e úlceras recorrentes. Nas últimas duas décadas, o tratamento antimicrobiano com cirurgia conservadora ou sem cirurgia tem sido proposto nas lesões do antepé, com resultados satisfatórios. Objetivo: apresentar os resultados do tratamento clínico da osteomielite do pé em pacientes diabéticos, priorizando ressecções mínimas que evitem amputações desestabilizadoras de sua biomecânica. Foram avaliados seis pacientes diabéticos (DM) atendidos na Unidade do Pé, com osteomielite de falanges, metatarsos e calcâneo, tratados com antibióticos por 7±2 semanas e ressecções limitadas ao antepé com boa evolução. Durante um ano de seguimento, não houve sinais de infecção no local inicial ou contíguo da lesão, preservando o suporte. Conclusão: a cirurgia com ressecção mínima sem amputação local ou de alto nível é bem-sucedida em casos selecionados de osteomielite do pé diabético. Ensaios prospectivos devem ser realizados para determinar os benefícios desta em relação a outras abordagens.


Assuntos
Osteomielite , Pé Diabético , Tratamento Conservador
5.
Rev. méd. Urug ; 37(3): e37302, set. 2021. tab, graf
Artigo em Espanhol | LILACS, BNUY | ID: biblio-1341550

RESUMO

Resumen: Las úlceras de pie diabético (UPD) generan un alto costo para el paciente y el sistema de salud. Una deficiente vascularización, la inhibición de la generación de factores de crecimiento y la migración celular, entre otros factores, influyen en su cronicidad. Los factores de crecimiento derivados de las plaquetas (PDGF) estimulan la quimiotaxis, la neovascularización y la regeneración tisular. Objetivo: evaluar la efectividad de una formulación de plasma rico en plaquetas autólogo (PRP) como una modalidad complementaria para el tratamiento de UPD, valorando su seguridad y efectos adversos. Materiales: estudio observacional. Se aplicó PRP a seis pacientes con UPD crónicas, Wagner II, III, con una media en el retraso de la cicatrización de 94 semanas. Se administró mediante punción y como gel sobre la lesión una vez por semana hasta el cierre de la úlcera o durante12 semanas. Las UPD se analizaron con respecto al área y su progresión mediante Mobile Wound Analyzer (MOWA), software de análisis de imágenes de úlceras. El porcentaje de reducción del área se calculó entre la medición inicial y la semana 12. Como criterio de mejoría se eligió una reducción >70% de la lesión. Resultados: predominó el sexo masculino con una media de edad de 53 años ± 7,3. Luego de 12 semanas de tratamiento, se reportó una reducción media del tamaño de la úlcera de 78%, con dos cicatrizaciones completas y dos en 99%. Un paciente recibió una amputación luego de presentar infección no controlada. Conclusión: la aplicación del PRP mejoró la regeneración de tejidos, acortando la duración de la úlcera, promoviendo su curación sin efectos adversos, al tiempo que eliminó la necesidad de procedimientos de manejo en una úlcera crónica.


Summary: Diabetic foot ulcers imply high expenditure for both patients and the health system. Vascular impairment, growth factor inhibition and cell migration, among other factors, affect the chronicity of the condition. Platelet-derived growth factors (PDGFs) stimulate chemotaxis, neovascularization and tissue regeneration. Objective: to evaluate effectiveness of a formulation of autologous platelet-rich plasma to complement the treatment of diabetic foot ulcer, assessing safety and adverse effects. Material: observational study. Platelet rich plasma was applied to six patients with chronic diabetic foot ulcer Wagner II, III, with an average delayed healing of 94 weeks. PRP gel was administered by puncture technique on the lesion, once a week until the ulcer healed or for 12 weeks. Diabetic foot ulcers were analysed in regards to surface area and progression through the Mobile Wound Analyzer (MOWA) software to analyse ulcer images. The area reduction percentage was calculated comparing the initial measurement and that of week 12. The improvement criteria was defined in a reduction that is >70% of the lesion. Results: men prevailed with an average age of 53 years ± 7.3. After 12 weeks of treatment an average reduction of 78% of the size of the ulcer was reported, two complete healings and two 99% healed. One patient required amputation because of uncontrolled infection. Conclusion: the application of PRP improved tissue regeneration and shortened the duration of the ulcer, promoting healing with no adverse effects, and it likewise eliminated the need for procedures to handle chronic ulcers.


Resumo: As úlceras do pé diabético (UPD) geram alto custo para o paciente e para o sistema de saúde. A vascularização deficiente, a inibição da geração de fatores de crescimento e migração celular, entre outros fatores, influenciam sua cronicidade. Os fatores de crescimento derivados de plaquetas (PDGF) estimulam a quimiotaxia, a neovascularização e a regeneração de tecidos. Objetivo: avaliar a eficácia de uma formulação autóloga de plasma rico em plaquetas (PRP) como modalidade complementar para o tratamento da UPD, avaliando sua segurança e efeitos adversos. Materiais: estudo observacional. O PRP foi aplicado a 6 pacientes com UPD crônica, Wagner II, III, com um atraso médio na cicatrização de 94 semanas. Foi administrado por punção e como gel sobre a lesão uma vez por semana até o fechamento da úlcera ou por 12 semanas. As UPD foram analisadas em relação à área e sua progressão, utilizando o software de análise de imagem de úlcera Mobile Wound Analyzer (MOWA). A redução percentual da área foi calculada entre a medição inicial e a semana 12. Como critério de melhora, optou-se pela redução > 70% da lesão. Resultados: predominou o sexo masculino com média de idade de 53 ± 7,3 anos. Após 12 semanas de tratamento, foi relatada uma redução média no tamanho da úlcera de 78%, sendo 2 com cicatrização completa e 2 em 99%. Um paciente foi amputado após desenvolver infecção descontrolada. Conclusão: a aplicação do PRP melhorou a regeneração tecidual, encurtando o tempo de duração da úlcera, promovendo sua cicatrização sem efeitos adversos, ao mesmo tempo que eliminava a necessidade de procedimentos de manejo na úlcera crônica.


Assuntos
Pé Diabético/terapia , Plasma Rico em Plaquetas , Úlcera do Pé/terapia
6.
Rev. méd. Urug ; 37(1): e37107, mar. 2021. tab, graf
Artigo em Espanhol | LILACS, BNUY | ID: biblio-1289844

RESUMO

Resumen: Una proporción importante de infecciones en el pie diabético consisten en onicomicosis y tinea pedis, problema común en el pie, amenazante de la viabilidad del tejido que puede provocar infecciones bacterianas secundarias. Requieren períodos prolongados de tratamiento antimicótico con alta tasas de recaídas y reinfección. Diversos estudios han mostrado la seguridad y eficacia de las nanopartículas de plata (NP Ag) como agente antimicrobiano. Realizamos un estudio donde se evaluó el tratamiento con NP Ag en dermatomicosis del pie de pacientes diabéticos. Método: estudio piloto, abierto, prospectivo, randomizado y controlado en pacientes que asisten a una policlínica de pie diabético. Dieciocho pacientes cumplieron con los criterios de inclusión conformándose dos grupos homogéneos. Ambos grupos recibieron tratamiento estándar que consistió en antimicótico tópico y desbastado mecánico. El grupo intervención utilizó un textil (medias) confeccionadas con hilos con NP Ag. Se realizó control clínico y microbiológico hasta las 12 semanas. Se evaluó el porcentaje de remisión y el tiempo hasta alcanzar el mismo. Resultados: predominó la onicomicosis y el germen Trichophyton rubrum. En el grupo intervención se logró un mayor porcentaje de remisión de lesiones y en un tiempo menor que el grupo control. Conclusiones: el uso de medias confeccionadas con hilos de NP Ag se asoció con una mayor probabilidad de curación completa en un período de 12 semanas a pesar de que el número de pacientes no permitió llegar al nivel de significación estadística, pudiendo contribuir a la prevención de infecciones o úlceras suplementarias en el pie diabético.


Summary: Onychomycosis and tinea pedis represent a significant proportion of infections in the diabetic foot, a common foot problem, and they constitute a threat to the viability of tissues that may provoke secondary bacterial infections. To combat them, antifungal treatments are required for long periods of time, the rates of relapse and reinfection being high. Several studies have proved the safety and effectiveness of silver nano particles (NP Ag) as an antimicrobial agent. A study was conducted to assess nanoparticle agents for foot dermatomycosis in diabetic patients. Method: pilot, open, prospective randomized and controlled study in patients who are assisted in a diabetic foot policlinic. 18 patients complied with the inclusion criteria and two homogeneous groups were formed. Both groups received standard treatment consisting in topic antifungal and mechanical roughing. The intervention groups used a textile (stockings) made with silver nanoparticle threads. Clinical and microbiological control was made during 12 weeks, also assessing the remission percentage and the time it took to achieve it. Resultados: onychomycosis and trichophyton rubrum prevailed. The intervention group showed a greater percentage of remission of lesions in a period of time that was shorter than that of the control group. Conclusions: the use of stockings made with NP Ag threads was associated with a greater probability of complete healing, in a 12-week period, despite the fact that the number of patients was not statistically significant. This could contribute to the prevention of supplementary infections or ulcers in the diabetic foot.


Resumo: Uma proporção significativa de infecções do pé diabético consiste em onicomicose e Tinea pedis, um problema comum nos pés que ameaça a viabilidade do tecido e pode causar infecções bacterianas secundárias. Requerem períodos prolongados de tratamento antifúngico com altas taxas de recidiva e reinfecção. Vários estudos têm demonstrado a segurança e a eficácia das nanopartículas de prata (NP Ag) como agente antimicrobiano. Realizamos um estudo onde o tratamento com NP Ag foi avaliado na dermatomicose do pé de pacientes diabéticos. Método: estudo piloto, aberto, prospectivo, randomizado e controlado em pacientes atendidos em uma policlínica de pé diabético. Dezoito pacientes preencheram os critérios de inclusão, formando dois grupos homogêneos. Ambos os grupos receberam tratamento padrão que consiste em antifúngico tópico e moagem mecânica. O grupo intervenção utilizou um tecido (meias) confeccionado com fios NP Ag. O controle clínico e microbiológico foi realizado até 12 semanas. A porcentagem de remissão e o tempo para alcançá-la foram avaliados. Resultados: predominaram a onicomicose e o germe Trichophyton rubrum. No grupo intervenção, obteve-se maior percentual de remissão das lesões e em menor tempo que o grupo controle. Conclusões: o uso de meias confeccionadas com fios NP Ag esteve associado a uma maior probabilidade de cura completa, no período de 12 semanas, apesar do número de pacientes não permitir atingir o nível de significância estatística, podendo contribuir para a prevenção de infecções ou úlceras adicionais no pé diabético.


Assuntos
Prata/uso terapêutico , Onicomicose/terapia , Pé Diabético , Nanopartículas Metálicas/uso terapêutico
7.
Environ Int ; 150: 106435, 2021 05.
Artigo em Inglês | MEDLINE | ID: mdl-33601224

RESUMO

BACKGROUND: Air pollution is a major environmental hazard to human health and a leading cause of morbidity for asthma worldwide. OBJECTIVES: To assess the current evidence on short-term effects (from several hours to 7 days) of exposure to ozone (O3), nitrogen dioxide (NO2), and sulphur dioxide (SO2) on asthma exacerbations, defined as emergency room visits (ERVs) and hospital admissions (HAs). METHODS: We searched PubMed/MEDLINE, EMBASE and other electronic databases to retrieve studies that investigated the risk of asthma-related ERVs and HAs associated with short-term exposure to O3, NO2, or SO2. We evaluated the risks of bias (RoB) for individual studies and the certainty of evidence for each pollutant in the overall analysis. A subgroup analysis was performed, stratified by sex, age, and type of asthma exacerbation. We conducted sensitivity analysis by excluding the studies with high RoB and based on the E-value. Publication bias was examined with the Egger's test and with funnel plots. RESULTS: Our literature search retrieved 9,059 articles, and finally 67 studies were included, from which 48 studies included the data on children, 21 on adults, 14 on the elderly, and 31 on the general population. Forty-three studies included data on asthma ERVs, and 25 on asthma HAs. The pooled relative risk (RR) per 10 µg/m3 increase of ambient concentrations was 1.008 (95%CI: 1.005, 1.011) for maximum 8-hour daily or average 24-hour O3, 1.014 (95%CI: 1.008, 1.020) for average 24-hour NO2, 1.010 (95%CI: 1.001, 1.020) for 24-hour SO2, 1.017 (95%CI: 0.973, 1.063) for maximum 1-hour daily O3, 0.999 (95%CI: 0.966, 1.033) for 1-hour NO2, and 1.003 (95%CI: 0.992, 1.014) for 1-hour SO2. Heterogeneity was observed in all pollutants except for 8-hour or 24-hour O3 and 24-hour NO2. In general, we found no significant differences between subgroups that can explain this heterogeneity. Sensitivity analysis based on the RoB showed certain differences in NO2 and SO2 when considering the outcome or confounding domains, but the analysis using the E-value showed that no unmeasured confounders were expected. There was no major evidence of publication bias. Based on the adaptation of the Grading of Recommendations Assessment, Development and Evaluation, the certainty of evidence was high for 8-hour or 24-hour O3 and 24-hour NO2, moderate for 24-hour SO2, 1-hour O3, and 1-hour SO2, and low for 1-hour NO2. CONCLUSION: Short-term exposure to daily O3, NO2, and SO2 was associated with an increased risk of asthma exacerbation in terms of asthma-associated ERVs and HAs.


Assuntos
Poluentes Atmosféricos , Poluição do Ar , Asma , Ozônio , Adulto , Idoso , Poluentes Atmosféricos/análise , Poluentes Atmosféricos/toxicidade , Poluição do Ar/efeitos adversos , Poluição do Ar/análise , Asma/induzido quimicamente , Asma/epidemiologia , Criança , Serviço Hospitalar de Emergência , Hospitais , Humanos , Dióxido de Nitrogênio/análise , Dióxido de Nitrogênio/toxicidade , Ozônio/análise , Ozônio/toxicidade , Material Particulado/análise , Dióxido de Enxofre/toxicidade
8.
Environ Int ; 150: 106434, 2021 05.
Artigo em Inglês | MEDLINE | ID: mdl-33601225

RESUMO

BACKGROUND: Many studies have assessed the harmful effects of ambient air pollution on human mortality, but the evidence needs further exploration, analysis, and refinement, given the large number of studies that have been published in recent years. The objective of this study was to evaluate all the available evidence of the effect of short-term exposure to ambient sulphur dioxide (SO2) on all-cause and respiratory mortality. METHODS: Articles reporting observational epidemiological studies were included, comprising time-series and case-crossover designs. A broad search and wide inclusion criteria were considered, encompassing international and regional databases, with no geographical or language restrictions. A random effect meta-analysis was conducted, and pooled relative risk for an increment of 10 µg/m3 in SO2 concentrations were calculated for each outcome. We analysed the risk of bias (RoB) in individual studies for specific domains using a new domain-based RoB assessment tool, and the certainty of evidence across studies with an adaptation of the Grading of Recommendations Assessment, Development and Evaluation approach. The certainty of evidence was judged separately for each exposure-outcome combination. A number of subgroup and sensitivity analyses were carried out, as well as assessments of heterogeneity and potential publication bias. The protocol for this review was registered with PROSPERO (CRD42019120738). RESULTS: Our search retrieved 1,128 articles, from which 67 were included in quantitative analysis. The RoB was low or moderate in the majority of articles and domains. An increment of 10 µg/m3 in SO2 (24-hour average) was associated with all-cause mortality (RR: 1.0059; 95% CI: 1.0046-1.0071; p-value: <0.01), and respiratory mortality (RR: 1.0067; 95% CI: 1.0025-1.0109; p-value: <0.01), while the same increment in SO2 (1-hour max.) was associated with respiratory mortality (RR:1.0052; 95% CI: 1.0013-1.0091; p-value: 0.03). Similarly, the association was positive but non-significant for SO2 (1-hour max.) and all-cause mortality (RR: 1.0016; 95% CI: 0.9930-1.0102; p-value: 0.60). These associations were still significant after the adjustment for particulate matter, but not for other pollutants, according to the results from 13 articles that evaluated co-pollutant models. In general, linear concentration-response functions with no thresholds were found for the two outcomes, although this was only evaluated in a small number of studies. We found signs of heterogeneity for SO2 (24-hour average) - respiratory mortality and SO2 (1-hour max.) - all-cause mortality, and funnel plot asymmetry for SO2 (24-hour average) - all-cause mortality. The certainty of evidence was high in two combinations, i.e. SO2 (24-hour average) - all-cause mortality and SO2 (1-hour max.) - respiratory mortality, moderate in one combination, i.e. SO2 (24-hour average) - respiratory mortality, and low in the remaining one combination. CONCLUSIONS: Positive associations were found between short-term exposure to ambient SO2 and all-cause and respiratory mortality. These associations were robust against several sensitivity analyses, and were judged to be of moderate or high certainty in three of the four exposure-outcome combinations.


Assuntos
Poluentes Atmosféricos , Poluição do Ar , Doenças Respiratórias , Poluentes Atmosféricos/análise , Poluentes Atmosféricos/toxicidade , Poluição do Ar/efeitos adversos , Poluição do Ar/análise , Humanos , Material Particulado/análise , Doenças Respiratórias/induzido quimicamente , Doenças Respiratórias/mortalidade , Dióxido de Enxofre/toxicidade
9.
Environ Int ; 142: 105876, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-32590284

RESUMO

BACKGROUND: Air pollution is a leading cause of mortality and morbidity worldwide. Short-term exposure (from one hour to days) to selected air pollutants has been associated with human mortality. This systematic review was conducted to analyse the evidence on the effects of short-term exposure to particulate matter with aerodynamic diameters less or equal than 10 and 2.5 µm (PM10, PM2.5), nitrogen dioxide (NO2), and ozone (O3), on all-cause mortality, and PM10 and PM2.5 on cardiovascular, respiratory, and cerebrovascular mortality. METHODS: We included studies on human populations exposed to outdoor air pollution from any source, excluding occupational exposures. Relative risks (RRs) per 10 µg/m3 increase in air pollutants concentrations were used as the effect estimates. Heterogeneity between studies was assessed using 80% prediction intervals. Risk of bias (RoB) in individual studies was analysed using a new domain-based assessment tool, developed by a working group convened by the World Health Organization and designed specifically to evaluate RoB within eligible air pollution studies included in systematic reviews. We conducted subgroup and sensitivity analyses by age, sex, continent, study design, single or multicity studies, time lag, and RoB. The certainty of evidence was assessed for each exposure-outcome combination. The protocol for this review was registered with PROSPERO (CRD42018087749). RESULTS: We included 196 articles in quantitative analysis. All combinations of pollutants and all-cause and cause-specific mortality were positively associated in the main analysis, and in a wide range of sensitivity analyses. The only exception was NO2, but when considering a 1-hour maximum exposure. We found positive associations between pollutants and all-cause mortality for PM10 (RR: 1.0041; 95% CI: 1.0034-1.0049), PM2.5 (RR: 1.0065; 95% CI: 1.0044-1.0086), NO2 (24-hour average) (RR: 1.0072; 95% CI: 1.0059-1.0085), and O3 (RR: 1.0043; 95% CI: 1.0034-1.0052). PM10 and PM2.5 were also positively associated with cardiovascular, respiratory, and cerebrovascular mortality. We found some degree of heterogeneity between studies in three exposure-outcome combinations, and this heterogeneity could not be explained after subgroup analysis. RoB was low or moderate in the majority of articles. The certainty of evidence was judged as high in 10 out of 11 combinations, and moderate in one combination. CONCLUSIONS: This study found evidence of a positive association between short-term exposure to PM10, PM2.5, NO2, and O3 and all-cause mortality, and between PM10 and PM2.5 and cardiovascular, respiratory and cerebrovascular mortality. These results were robust through several sensitivity analyses. In general, the level of evidence was high, meaning that we can be confident in the associations found in this study.


Assuntos
Poluentes Atmosféricos , Poluição do Ar , Ozônio , Poluentes Atmosféricos/análise , Poluentes Atmosféricos/toxicidade , Poluição do Ar/efeitos adversos , Poluição do Ar/análise , Causas de Morte , Exposição Ambiental/efeitos adversos , Exposição Ambiental/análise , Humanos , Dióxido de Nitrogênio/análise , Dióxido de Nitrogênio/toxicidade , Ozônio/análise , Ozônio/toxicidade , Material Particulado/análise , Material Particulado/toxicidade , Fatores de Tempo
10.
Rev. chil. endocrinol. diabetes ; 13(3): 110-117, 2020. ilus
Artigo em Espanhol | LILACS | ID: biblio-1117582

RESUMO

OBJETIVO: El yodo radiactivo (131I) es una opción terapeútica segura y eficaz cuando se utiliza solo o con la estimulación previa de TSH recombinante humana (rhTSH) en el tratamiento del bocio multinodular (BMN). En espera de ensayos clínicos que determinen la dosis óptima, demuestren seguridad y confirmen la eficacia, diferentes protocolos se utilizan para aplicar la dosis de 131I. Analizamos la respuesta al tratamiento con una dosis calculada por protocolo mixto (dosis fijas y cálculo por porcentaje de captación) en pacientes con BMN toxico y no toxico en nuestro hospital, en el periodo 2010-2013. MATERIALES Y MÉTODOS: Estudio prospectivo en pacientes con BMN no quirúrgico (BMNNQ) que requerían reducción del volumen glandular y/o tratamiento del hipertiroidismo. Se evaluaron 134 pacientes, 14 cumplieron con los criterios de inclusión (13mujeres) de edad media 71.08 años. Un grupo con BMN toxico, otro grupo con BMN no toxico, un tercer grupo con BMN no toxico estimulado con 0,1 mg de rhTSH previo a la dosis. Se evaluó, función tiroidea, captación tiroidea de 99ᵐTc, volumen tiroideo y síntomas compresivos. Se siguió a los pacientes durante 12 meses. RESULTADOS: Se aplicaron dosis entre 15 y 30 mCi de 131I. Remitió el hipertiroidismo en 6 de 7 pacientes. Hubo una reducción del volumen glandular (p<0.01).Los pacientes con estímulo de 0,1 mg rhTSH, aumentaron el porcentaje de captación de 99ᵐTc a las 24 h en un 32.43±10.61 permitiendo aplicar menor dosis de 131I. La tasa de aparición de hipotiroidismo fue de 7.41 por cada 100 pacientes.mes, mayor en pacientes con BMN toxico tratados con dosis bajas (p-=0.03). Hubo una mejoría subjetiva de la clínica compresiva en todos los pacientes. No hubo eventos adversos. CONCLUSIONES: Una dosis de 131I calculada por protocolo mixto es efectiva y segura para la reducción del volumen glandular y control del hipertiroidismo asociado. La estimulación con rhTSH logra el mismo efecto con una menor dosis administrada.


OBJECTIVE: Radioactive iodine (131I) is a safe and effective therapeutic option when used alone or with prior stimulation of recombinant human Thyrotropin (rhTSH) in the treatment of multinodular goiter (MNG). In absence of clinical trials that determine the optimal dose, demonstrate safety and confirm efficacy, different protocols are used to apply the dose of 131I. We analyze the response to treatment with a dose calculated by mixed protocol (fixed doses and calculation by percentage of uptake) in patients with toxic and non-toxic MNG in our hospital, in the period 2010-2013. MATERIALS AND METHODS: Prospective study in patients with non-surgical MNG that required glandular volume reduction and / or treatment of hyperthyroidism. 134 patients were evaluated, 14 met the inclusion criteria (13 women) of average age 71.08 years. One group with toxic MNG, another group with non-toxic MNG and a third with non-toxic multinodular goiter stimulated with 0.1 mg of rhTSH prior to the dose. Patients were followed for 12 months. Upon following, we assessed Thyroid function, 99ᵐTc thyroid uptake, thyroid volume and compressive symptoms. RESULTS: Doses between 15 and 30 mCi of 131I were applied. We observed hyperthyroidism remission in 6 of 7 patients. There was a reduction in glandular volume (p <0.01) considering all patients. Patients with a stimulus of 0.1 mg rhTSH, increased the percentage of uptake of 99ᵐTc at 24 h by 32.43 ± 10.61, allowing a lower dose of 131I to be applied. The rate of onset of hypothyroidism was 7.41 per 100 patients-month, and was higher in patients with toxic MNG treated with low doses (p = 0.03). There was a subjective improvement of the compression clinic in all patients. No adverse events were observed. CONCLUSIONS: A dose of 131I calculated by a mixed protocol is effective and safe for achieving glandular volume reduction and associated hyperthyroidism control. Stimulation with rhTSH produces the same effect with a lower administered dose.


Assuntos
Humanos , Masculino , Feminino , Idoso , Tirotropina Alfa/uso terapêutico , Bócio Nodular/radioterapia , Radioisótopos do Iodo/uso terapêutico , Fatores de Tempo , Indução de Remissão , Estudos Prospectivos , Resultado do Tratamento , Terapia Combinada , Pertecnetato Tc 99m de Sódio , Bócio Nodular/diagnóstico por imagem
11.
J Infect Prev ; 19(4): 168-176, 2018 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-30013621

RESUMO

OBJECTIVE: To analyse the impact of the International Nosocomial Infection Control Consortium (INICC) multidimensional approach (IMA) on ventilator-associated pneumonia (VAP) rates in three intensive care units (ICUs) from two hospitals in Kuwait City from January 2014 to March 2015. DESIGN: A prospective, before-after study on 2507 adult ICU patients. During baseline, we performed outcome surveillance of VAP applying CDC/NHSN definitions. During intervention, we implemented the IMA through the INICC Surveillance Online System (ISOS), which included: (1) a bundle of infection prevention interventions; (2) education; (3) outcome surveillance; and (4) feedback on VAP rates and consequences. Logistic regression analysis was performed to estimate the effect of the intervention on VAP, controlling for potential bias. RESULTS: During baseline, 1990 mechanical ventilator (MV)-days and 14 VAPs were recorded, accounting for 7.0 VAPs per 1000 MV-days. During intervention, 9786 MV-days and 35 VAPs were recorded, accounting for 3.0 VAPs per 1000 MV-days. The VAP rate was reduced by 57.1% (incidence-density ratio = 0.51; 95% CI = 0.28-0.93; p = 0.042). Logistic regression showed a significant reduction in VAP rate during the intervention phase (OR = 0.39, 95% CI = 0.18-0.83), with 61% effectiveness. CONCLUSIONS: Implementing IMA through ISOS was associated with a significant reduction in the VAP rate in Kuwait ICUs.

12.
Rev. méd. Urug ; 34(3): 155-163, jul. 2018.
Artigo em Espanhol | LILACS | ID: biblio-915009

RESUMO

La diabetes mellitus tipo 2 es debida a la insulino-resistencia en el 90% de los casos y es determinante de riesgo para demencia vascular y enfermedad de Alzheimer. La inflamación, sistémica y crónica, de bajo grado de intensidad determina pérdida de sensibilidad a la insulina en el cerebro y deterioro cognitivo. El objetivo de este trabajo fue evaluar el impacto de un programa de ejercicio de 20 semanas sobre el estatus cognitivo (incluyendo calidad de vida) e inflamatorio en una muestra de diabéticos mellitus tipo 2 cuyo diagnóstico es menor o igual a diez años, asistidos por nuestro Sistema Nacional Integrado de Salud (SNIS). Método: el estudio fue clínico, abierto, randomizado y controlado con pacientes en nivel primario de atención. De los 168 pacientes diabéticos tipo 2 reclutados, 41 cumplieron con los criterios de inclusión. La muestra fue dividida en dos grupos homogéneos. A ambos grupos se les aplicó una batería de tests cognitivos y extracciones de sangre para medir marcadores inflamatorios y metabólicos antes y después del programa de ejercicio. Resultados: en el grupo de intervención, la mejoría cognitiva y calidad de vida estuvieron relacionadas al descenso significativo de los marcadores de inflamación IL-6 y ferritina, así como de marcadores metabólicos. En contraste, el grupo control no mostró ninguna mejoría. Conclusiones: una aplicación precoz y periódica del programa de 20 semanas de ejercicio controlado u otro similar en el tratamiento de los diabéticos mellitus tipo 2 asistidos por nuestro SNIS puede contribuir en la prevención del deterioro cognitivo y la enfermedad de Alzheimer. (AU)


Diabetes mellitus type 2 is a disorder caused by insulin resistance in 90 per cent of cases and determines risk of vascular dementia and Alzheimer's disease. Low grade chronic and systemic inflammation determines a loss in insulin sensitivity in the brain and cognitive deterioration. The study aimed to assess the impact of a 20 week exercise program on the cognitive (including quality of life) and inflammatory status in a sample of patients with type 2 diabetes mellitus whose diagnosis is ten years or less, assisted in our national integrated health system. Method: clinical, open, randomised and controlled study on patients of the primary level of care. 41 out of 168 patients with type 2 diabetes mellitus recruited met the inclusion criteria. The sample was divided into two homogeneous groups. Both groups underwent cognitive tests and blood samples were taken to measure inflammatory and metabolic markers, before and after the exercise program. Results: cognitive and quality of life improvement were correlated to a significant decrease of inflammation markers: IL-6 and ferritin, as well as of metabolic markers. Unlike this, no improvement was seen in the control group. Conclusions: early and regular application of the 20 week controlled exercise program or similar to treat patients with type 2 diabetes mellitus who are followed by our national integrated health system may contribute to preventing cognitive deterioration and Alzheimer's disease. (AU)


A diabetes mellitus tipo 2, em 90% dos casos, é devida à insulina-resistência e é um determinante de risco para demência vascular e doença de Alzheimer. A inflamação sistêmica e crônica, de baixo grau de intensidade determina perda de sensibilidade à insulina no cérebro e deterioro cognitivo. O objetivo deste trabalho foi avaliar o impacto de um programa de exercícios de vinte semanas sobre o status cognitivo (incluindo qualidade de vida) e inflamatório em uma amostra de diabéticos mellitus tipo 2 cujo diagnóstico foi realizado em um período menor ou igual a dez anos, atendidos no sistema nacional integrado de salud. Método: o estudio foi clínico, aberto, randomizado e controlado com pacientes atendidos no primeiro nível de atenção. Dos168 pacientes diabéticos tipo 2 recrutados, 41 cumpriam com os critérios de inclusão. A amostra foi dividida em dois grupos homogêneos. Ambos os grupos foram submetidos a uma bateria de testes cognitivos e coleta de sangue para medir marcadores inflamatórios e metabólicos, antes e depois do programa de exercícios. Resultados: no grupo de intervenção, a melhoria cognitiva e de qualidade de vida estavam relacionadas a diminuição significativa dos marcadores de inflamação: IL-6 e ferritina, bem como dos marcadores metabólicos. No entanto, o grupo controle não mostrou nenhuma melhoria. Conclusões: a aplicação precoce e periódica do programa de vinte semanas de exercícios controlados, ou outro similar, no tratamento dos pacientes diabéticos mellitus tipo 2 atendidos no sistema nacional integrado de saúde (SNIS) pode contribuir para a prevenção do deterioro cognitivo e da doença de Alzheimer. (AU)


Assuntos
Qualidade de Vida , Exercício Físico , Diabetes Mellitus Tipo 2
13.
J Infect Public Health ; 11(5): 677-684, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29945849

RESUMO

BACKGROUND: To analyze the impact of the International Nosocomial Infection Control Consortium (INICC) Multidimensional Approach (IMA) and use of INICC Surveillance Online System (ISOS) on ventilator-associated pneumonia (VAP) rates in Saudi Arabia from September 2013 to February 2017. METHODS: A multicenter, prospective, before-after surveillance study on 14,961 patients in 37 intensive care units (ICUs) of 22 hospitals. During baseline, we performed outcome surveillance of VAP applying the definitions of the CDC/NHSN. During intervention, we implemented the IMA and the ISOS, which included: (1) a bundle of infection prevention practice interventions, (2) education, (3) outcome surveillance, (4) process surveillance, (5) feedback on VAP rates and consequences and (6) performance feedback of process surveillance. Bivariate and multivariate regression analyses were performed using generalized linear mixed models to estimate the effect of intervention. RESULTS: The baseline rate of 7.84 VAPs per 1000 mechanical-ventilator (MV)-days-with 20,927 MV-days and 164 VAPs-, was reduced to 4.74 VAPs per 1000 MV-days-with 118,929 MV-days and 771 VAPs-, accounting for a 39% rate reduction (IDR 0.61; 95% CI 0.5-0.7; P 0.001). CONCLUSIONS: Implementing the IMA was associated with significant reductions in VAP rates in ICUs of Saudi Arabia.


Assuntos
Infecções Bacterianas/epidemiologia , Infecções Bacterianas/prevenção & controle , Controle de Infecções/métodos , Unidades de Terapia Intensiva , Pacotes de Assistência ao Paciente/métodos , Pneumonia Associada à Ventilação Mecânica/epidemiologia , Pneumonia Associada à Ventilação Mecânica/prevenção & controle , Adulto , Idoso , Idoso de 80 Anos ou mais , Cidades/epidemiologia , Feminino , Fidelidade a Diretrizes , Hospitais , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Estudos Prospectivos , Arábia Saudita/epidemiologia , Adulto Jovem
14.
Rev Panam Salud Publica ; 41: e120, 2018 Feb 19.
Artigo em Inglês | MEDLINE | ID: mdl-29466517

RESUMO

OBJECTIVE: To assess the potential occurrence of Zika transmission throughout Argentina by the mosquito Aedes aegypti considering the basic reproduction number (R0). METHODS: A model originally developed for dengue was adapted for Zika. R0 was estimated as a function of seven parameters, three of them were considered temperature-dependent. Seasonal Zika occurrence was evaluated in 9 locations representing different climatic suitability for the vector. Data of diary temperatures were extracted and included in the model. A threshold of R0 = 1 was fixed for Zika occurrence. Sensitivity analyses were performed to evaluate the uncertainty around the results. RESULTS: Zika transmission has the potential to occur in all studied locations at least in some moment of the year. In the northern region, transmission might be possible throughout the whole year or with an interruption in winter. The maximum R0 was estimated in 6.9, which means an average of 7 secondary cases from a primary case. The probabilistic sensitivity analysis showed that during winter the transmission can only be excluded in the southern fringe of geographic distribution of the vector and in part of central Argentina. CONCLUSION: Zika virus has the potential to be transmitted in Argentina throughout the current geographic range of the mosquito vector. Although the transmission would be mainly seasonal, the possibility of winter transmission cannot be excluded in northern and central Argentina, meaning that there is a potential endemic maintenance of the disease.

15.
Infect Control Hosp Epidemiol ; 39(4): 445-451, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29427997

RESUMO

OBJECTIVE To analyze the impact of the International Nosocomial Infection Control Consortium (INICC) Multidimensional Approach (IMA) and the INICC Surveillance Online System (ISOS) on central line-associated bloodstream infection (CLABSI) rates in 14 intensive care units (ICUs) in Argentina from January 2014 to April 2017. DESIGN This prospective, pre-post surveillance study of 3,940 ICU patients was conducted in 11 hospitals in 5 cities in Argentina. During our baseline evaluation, we performed outcome and process surveillance of CLABSI applying Centers for Disease Control and Prevention/National Health Safety Network (CDC/NHSN) definitions. During the intervention, we implemented the IMA through ISOS: (1) a bundle of infection prevention practice interventions, (2) education, (3) outcome surveillance, (4) process surveillance, (5) feedback on CLABSI rates and consequences, and (6) performance feedback of process surveillance. Bivariate and multivariate regression analyses were performed using a logistic regression model to estimate the effect of the intervention on the CLABSI rate. RESULTS During the baseline period, 5,118 CL days and 49 CLABSIs were recorded, for a rate of 9.6 CLABSIs per 1,000 central-line (CL) days. During the intervention, 15,659 CL days and 68 CLABSIs were recorded, for a rate of 4.1 CLABSIs per 1,000 CL days. The CLABSI rate was reduced by 57% (incidence density rate: 0.43; 95% confidence interval, 0.34-0.6; P<.001). CONCLUSIONS Implementing IMA through ISOS was associated with a significant reduction in the CLABSI rate in ICUs in Argentina. Infect Control Hosp Epidemiol 2018;39:445-451.


Assuntos
Bacteriemia , Infecções Relacionadas a Cateter , Cateteres Venosos Centrais/efeitos adversos , Infecção Hospitalar , Controle de Infecções , Argentina/epidemiologia , Bacteriemia/epidemiologia , Bacteriemia/etiologia , Bacteriemia/prevenção & controle , Infecções Relacionadas a Cateter/epidemiologia , Infecções Relacionadas a Cateter/etiologia , Infecções Relacionadas a Cateter/prevenção & controle , Infecção Hospitalar/epidemiologia , Infecção Hospitalar/prevenção & controle , Humanos , Incidência , Controle de Infecções/métodos , Controle de Infecções/organização & administração , Avaliação de Processos e Resultados em Cuidados de Saúde , Avaliação de Programas e Projetos de Saúde/estatística & dados numéricos , Fatores de Risco
16.
Am J Infect Control ; 46(6): 674-679, 2018 06.
Artigo em Inglês | MEDLINE | ID: mdl-29329916

RESUMO

BACKGROUND: To analyze the impact of the International Nosocomial Infection Control Consortium (INICC) multidimensional approach (IMA) on ventilator-associated pneumonia (VAP) rates in 11 hospitals within 5 cities of Argentina from January 2014-April 2017. METHODS: A multicenter, prospective, before-after surveillance study was conducted through the use of International Nosocomial Infection Control Consortium Surveillance Online System. During baseline, we performed outcome surveillance of VAP applying the definitions of the Centers for Disease Control andPrevention's National Healthcare Safety Network. During intervention, we implemented the IMA, which included a bundle of infection prevention practice interventions, education, outcome surveillance, process surveillance, feedback on VAP rates and consequences, and performance feedback of process surveillance. Bivariate and multivariate regression analyses were performed using a logistic regression model to estimate the effect of the intervention. RESULTS: We recorded 3,940 patients admitted to 14 intensive care units. At baseline, there were 19.9 VAPs per 1,000 mechanical ventilator (MV)-days-with 2,920 MV-days and 58 VAPs, which was reduced during intervention to 9.4 VAPs per 1,000 MV-days-with 9,261 MV-days and 103 VAPs. This accounted for a 52% rate reduction (incidence density rate, 0.48; 95% confidence interval, 0.3-0.7; P .001). CONCLUSIONS: Implementing the IMA was associated with significant reductions in VAP rates in intensive care units within Argentina.


Assuntos
Infecção Hospitalar/epidemiologia , Infecção Hospitalar/prevenção & controle , Controle de Infecções/métodos , Unidades de Terapia Intensiva , Pneumonia Associada à Ventilação Mecânica/epidemiologia , Pneumonia Associada à Ventilação Mecânica/prevenção & controle , Adulto , Idoso , Idoso de 80 Anos ou mais , Argentina/epidemiologia , Cidades/epidemiologia , Feminino , Hospitais , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos
17.
Vaccine ; 36(7): 979-985, 2018 02 08.
Artigo em Inglês | MEDLINE | ID: mdl-29331246

RESUMO

BACKGROUND: Current recommendations about dengue vaccination by the World Health Organization depend on seroprevalence levels and serological status in populations and individuals. However, seroprevalence estimation may be difficult due to a diversity of factors. Thus, estimation through models using data from epidemiological surveillance systems could be an alternative procedure to achieve this goal. OBJECTIVE: To estimate the expected dengue seroprevalence in children of selected areas in Argentina, using a simple model based on data from passive epidemiological surveillance systems. METHODS: A Markov model using a simulated cohort of individuals from age 0 to 9 years was developed. Parameters regarding the reported annual incidence of dengue, proportion of inapparent cases, and expansion factors for outpatient and hospitalized cases were considered as transition probabilities. The proportion of immune population at 9 years of age was taken as a proxy of the expected seroprevalence, considering this age as targeted for vaccination. The model was used to evaluate the expected seroprevalence in Misiones and Salta provinces and in Buenos Aires city, three settings showing different climatic favorability for dengue. RESULTS: The estimates of the seroprevalence for the group of 9-year-old children for Misiones was 79% (95%CI:46-100%), and for Salta 22% (95%CI:14-30%), both located in northeastern and northwestern Argentina, respectively. Buenos Aires city, from central Argentina, showed a likely seroprevalence of 7% (95%CI: 3-11%). According to the deterministic sensitivity analyses, the parameter showing the highest influence on these results was the probability of inapparent cases. CONCLUSIONS: This model allowed the estimation of dengue seroprevalence in settings where this information is not available. Particularly for Misiones, the expected seroprevalence was higher than 70% in a wide range of scenarios, thus in this province a vaccination strategy directed to seropositive children of >9 years should be analyzed, including further considerations as safety, cost-effectiveness, and budget impact.


Assuntos
Dengue/epidemiologia , Vigilância em Saúde Pública , Estudos Soroepidemiológicos , Argentina/epidemiologia , Criança , Pré-Escolar , Dengue/prevenção & controle , Feminino , Humanos , Programas de Imunização , Incidência , Lactente , Recém-Nascido , Masculino , Cadeias de Markov , Método de Monte Carlo , Avaliação de Programas e Projetos de Saúde , Vacinação
18.
J Asthma ; 55(11): 1174-1186, 2018 11.
Artigo em Inglês | MEDLINE | ID: mdl-29211546

RESUMO

OBJECTIVE: This study aimed to evaluate the association between asthma prevalence and outdoor air pollution in children in Latin America and the Caribbean. DATA SOURCES: We searched studies in global and regional databases: PubMed, Scopus, LILACS and SciELO. STUDY SELECTION: Articles following a cross-sectional design, studying children from 0 to 18 years old, and comparing the prevalence of asthma in two or more areas of LAC countries with different air pollution levels were included. The exclusion criteria comprised air pollution not related to human activities. RESULTS: Database searches retrieved 384 records, while 20 studies were retained for qualitative and 16 for quantitative analysis, representing 48 442 children. We found a positive association, i.e. a higher prevalence of asthma in children living in a polluted environment, with pooled odds ratio (OR) of 1.34 (95% CI: 1.17-1.54). Heterogeneity between studies was moderate (I2: 68.39%), while the risk of bias was intermediate or high in 14 studies. In all the subgroup and sensitivity analyses, the pooled ORs were significant and higher than those found in the general analysis Conclusions: Our results showed that living in a polluted environment is significantly associated with children having asthma in LAC. Limitations of this study include the low number of studies performed in LAC countries, differences in methodologies and the risk of bias in individual studies.


Assuntos
Poluição do Ar/análise , Asma/epidemiologia , Exposição Ambiental/estatística & dados numéricos , Adolescente , Fatores Etários , Asma/induzido quimicamente , Monóxido de Carbono/efeitos adversos , Monóxido de Carbono/análise , Região do Caribe/epidemiologia , Criança , Pré-Escolar , Estudos Transversais , Exposição Ambiental/efeitos adversos , Feminino , Humanos , Lactente , América Latina/epidemiologia , Masculino , Óxido Nítrico/efeitos adversos , Óxido Nítrico/análise , Ozônio/efeitos adversos , Ozônio/análise , Material Particulado/efeitos adversos , Material Particulado/análise , Prevalência , Dióxido de Enxofre/efeitos adversos , Dióxido de Enxofre/análise
19.
Artigo em Inglês | PAHO-IRIS | ID: phr-34437

RESUMO

Objective. To assess the potential occurrence of Zika transmission throughout Argentina by the mosquito Aedes aegypti considering the basic reproduction number (R0). Methods. A model originally developed for dengue was adapted for Zika. R0 was estimated as a function of seven parameters, three of them were considered temperature-dependent. Seasonal Zika occurrence was evaluated in 9 locations representing different climatic suitability for the vector. Data of diary temperatures were extracted and included in the model. A threshold of R0 = 1 was fixed for Zika occurrence. Sensitivity analyses were performed to evaluate the uncertainty around the results. Results. Zika transmission has the potential to occur in all studied locations at least in some moment of the year. In the northern region, transmission might be possible throughout the whole year or with an interruption in winter. The maximum R0 was estimated in 6.9, which means an average of 7 secondary cases from a primary case. The probabilistic sensitivity analysis showed that during winter the transmission can only be excluded in the southern fringe of geographic distribution of the vector and in part of central Argentina. Conclusion. Zika virus has the potential to be transmitted in Argentina throughout the current geographic range of the mosquito vector. Although the transmission would be mainly seasonal, the possibility of winter transmission cannot be excluded in northern and central Argentina, meaning that there is a potential endemic maintenance of the disease.


Objetivo. Evaluar la posibilidad de transmisión de zika en la Argentina por el mosquito Aedes aegypti considerando el número de reproducción básica (R0). Métodos. Se adaptó para el zika un modelo desarrollado originalmente para el dengue. Se estimó R0 en función de siete parámetros, tres de los cuales se consideraron dependientes de la temperatura. Se evaluó la ocurrencia estacional de zika en nueve localidades que representan diferente aptitud climática para el vector. Se obtuvieron los datos de las temperaturas diarias y se incluyeron en el modelo. Se fijó un umbral de R0 = 1 para la ocurrencia de zika. Se realizaron análisis de sensibilidad para evaluar la incertidumbre de los resultados. Resultados. En todos los lugares estudiados es posible la transmisión de zika al menos en algún momento del año. En la región norte, la transmisión podría ser posible durante todo el año o con una interrupción en invierno. Se estimó el R0 máximo en 6,9, lo que significa un promedio de siete casos secundarios a partir de un caso primario. El análisis de sensibilidad probabilística demostró que durante el invierno la transmisión sólo puede ser excluida en la franja sur de distribución geográfica del vector y en parte de la región central de Argentina. Conclusión. El virus del Zika puede ser transmitido en Argentina en todo el rango geográfico actual del mosquito vector. Aunque la transmisión sería principalmente estacional, no es posible descartar la posibilidad de transmisión invernal en el norte y centro de la Argentina, lo que significa que la enfermedad puede mantenerse de manera endémica.


Objetivo. Avaliar a ocorrência potencial de transmissão de zika em Argentina pelo mosquito Aedes aegypti considerando o número de reprodução básico (R0). Métodos. Foi adaptado para zika um modelo originalmente desenvolvido para dengue. R0 foi estimado como uma função de sete parâmetros, três deles considerados dependentes da temperatura. A ocorrência de zika sazonal foi avaliada em nove locais que representam diferentes adequações climáticas para o vetor. Os dados das temperaturas diárias foram extraídos e incluídos no modelo. Um limite de R0 = 1 foi fixado para a ocorrência de zika, e foram realizadas análises de sensibilidade para avaliar a incerteza em torno dos resultados. Resultados. A transmissão de zika pode ocorrer em todos os locais estudados pelo menos em algum momento do ano. Na região norte, a transmissão pode ser possível durante todo o ano ou com uma interrupção no inverno. O R0 máximo foi estimado em 6.9, o que significa uma média de 7 casos secundários a partir de um caso primário. A análise de sensibilidade probabilística mostrou que durante o inverno a transmissão só pode ser excluída na franja sul da distribuição geográfica do vetor e em parte da Argentina central. Conclusão. O vírus Zika tem o potencial de ser transmitido na Argentina ao longo da atual faixa geográfica do vetor. Embora a transmissão seja principalmente sazonal, a possibilidade de transmissão no inverno não pode ser excluída no norte e centro da Argentina, o que significa que existe uma potencial manutenção endêmica da doença.


Assuntos
Infecção por Zika virus , Aedes , Vetores de Doenças , Argentina , Vetores de Doenças , Modelos Epidemiológicos , Infecção por Zika virus , Infecção por Zika virus , Vetores de Doenças
20.
J Infect Prev ; 18(1): 25-34, 2017 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-28989500

RESUMO

OBJECTIVE: To analyse the impact of the International Nosocomial Infection Control Consortium (INICC) Multidimensional Approach (IMA) and INICC Surveillance Online System (ISOS) on central line-associated bloodstream infection (CLABSI) rates in five intensive care units (ICUs) from October 2013 to September 2015. DESIGN: Prospective, before-after surveillance study of 3769 patients hospitalised in four adult ICUs and one paediatric ICU in five hospitals in five cities. During baseline, we performed outcome and process surveillance of CLABSI applying CDC/NHSN definitions. During intervention, we implemented IMA and ISOS, which included: (1) a bundle of infection prevention practice interventions; (2) education; (3) outcome surveillance; (4) process surveillance; (5) feedback on CLABSI rates and consequences; and (6) performance feedback of process surveillance. Bivariate and multivariate regression analyses were performed. RESULTS: During baseline, 4468 central line (CL) days and 31 CLABSIs were recorded, accounting for 6.9 CLABSIs per 1000 CL-days. During intervention, 12,027 CL-days and 37 CLABSIs were recorded, accounting for 3.1 CLABSIs per 1000 CL-days. The CLABSI rate was reduced by 56% (incidence-density rate, 0.44; 95% confidence interval, 0.28-0.72; P = 0.001). CONCLUSIONS: Implementing IMA through ISOS was associated with a significant reduction in the CLABSI rate in the ICUs of Saudi Arabia.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...